News
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
Ozempic's double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms
Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...
President Trump shared a story about a businessman friend's frustration with the high cost of a weight-loss drug in the U.S.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
Experts say weight management drugs have created an unsustainable surge in health care spending, with some insurance ...
It found that people on GLP-1 drugs like Wegovy and Ozempic reported eating fewer processed foods, red meat and sugary drinks ...
The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...
The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results